Sangamo Therapeutics, Inc. (LON:0R1D)

Sangamo Therapeutics Revenue

Sangamo Therapeutics had revenue of $18.31M USD in the quarter ending June 30, 2025, with 5,042.13% growth. This brings the company's revenue in the last twelve months to $81.71M, up 565.52% year-over-year. In the year 2024, Sangamo Therapeutics had annual revenue of $57.80M, down -67.20%.

• Revenue (ttm): $81.71M
• Revenue Growth: +565.52%
• P/S Ratio: 2.41
• Revenue / Employee: $446.48K
• Employees: 183
• Market Cap: 143.61M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	57.80M	-118.43M	-67.20%
Dec 31, 2023	176.23M	64.93M	58.34%
Dec 31, 2022	111.30M	598.00K	0.54%
Dec 31, 2021	110.70M	-7.49M	-6.34%
Dec 31, 2020	118.19M	15.76M	15.39%